Male | Jotup

Atsena Therapeutics Announces Initiation of Dosing in Second Cohort of Phase I/II Clinical Trial Evaluating ATSN-201 Gene Therapy for the Treatment of X-linked Retinoschisis (XLRS)

Retrieved on:

Wednesday, March 13, 2024

Gene expression, Safety, Patient, Data, MD, Male, Clinical trial, Therapy, Paratriathlon, RS1, Pharmaceutical industry

ATSN-201, a best-in-class gene therapy product candidate, leverages AAV.SPR, the company’s novel spreading capsid, to achieve therapeutic levels of gene expression in photoreceptors of the central retina while avoiding the surgical risks of foveal detachment.

Key Points:

ATSN-201, a best-in-class gene therapy product candidate, leverages AAV.SPR, the company’s novel spreading capsid, to achieve therapeutic levels of gene expression in photoreceptors of the central retina while avoiding the surgical risks of foveal detachment.
ATSN-201 was well tolerated in all three XLRS patients in the first cohort and no serious adverse events were reported.
The Data and Safety Monitoring Board recommended proceeding with the second cohort, in which patients will receive the next dose level of ATSN-201.
"We are encouraged by the excellent safety observed with the low dose of ATSN-201 in the LIGHTHOUSE study, which represents the first clinical utilization of AAV.SPR.

MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment

Retrieved on:

Tuesday, March 12, 2024

Growth, Patient, Ageing, TRT, Social media, Telehealth, Athlete, Male, Injection, Erectile dysfunction, Marketing, FDA, National library, Pharmaceutical industry

Dallas, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product (‘GROW’) and erectile dysfunction (ED) drug (‘Mango’), is excited to announce the highly anticipated release and availability of ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ (“PRIME”) bringing the FDA-approved oral testosterone replacement therapy (TRT) treatment to consumers across the U.S via its proprietary telehealth platform.

Key Points:

Those interested in speaking with a medical provider to obtain a prescription for PRIME can do so by visiting MangoRx’s website at https://www.mangorx.com/app/prime .
Furthermore, the introduction of oral testosterone therapy presents a compelling opportunity to tap into a significant addressable market.
By offering an alternative to injectable TRT, oral therapy addresses the concerns of individuals who are hesitant or unwilling to undergo injections.
This segment of the market, encompassing those with needle aversion, represents a substantial portion of the population and presents a compelling case for the viability and potential growth of oral testosterone therapy.

Recent Research Supports Sedation-Free TNE for Effective Management of GI Disorders Utilizing the EvoEndo System

Retrieved on:

Wednesday, April 3, 2024

Recently published scientific abstracts and peer-reviewed papers support the efficacy and demand for gastroenterology programs to offer Sedation-Free Transnasal Endoscopy (TNE) utilizing the EvoEndo System as an alternative to traditional TNE.

Key Points:

Recently published scientific abstracts and peer-reviewed papers support the efficacy and demand for gastroenterology programs to offer Sedation-Free Transnasal Endoscopy (TNE) utilizing the EvoEndo System as an alternative to traditional TNE.
Findings suggest a valuable opportunity to optimize the patient experience, minimize risks associated with anesthesia, and improve diagnostic outcomes.
There were no adverse events, suggesting promising potential for TNE as a diagnostic tool in assessing esophageal disorders.
These studies highlight the advantages of offering unsedated TNE and the viability of broader applications in pediatric endoscopy.

Vision & Voice, an Inclusive Community for Female Cybersecurity Leaders, Announces its Advisory Board

Retrieved on:

Wednesday, April 3, 2024

Today, Vision & Voice , a nonprofit organization dedicated to empowering the next generation of female leaders in cybersecurity, unveiled its official Advisory Board, a prominent committee of seasoned female professionals.

Key Points:

Today, Vision & Voice , a nonprofit organization dedicated to empowering the next generation of female leaders in cybersecurity, unveiled its official Advisory Board, a prominent committee of seasoned female professionals.
The Vision & Voice Advisory Board will help the community’s 600+ members build, fortify and grow each successive generation of female talent entering and ascending in the workforce.
Together with the newest members of our advisory board, Vision & Voice remains committed to creating more leadership and growth opportunities for women in cybersecurity professions.”
The fourteen members of the Vision & Voice Advisory Board represent more than 260 years of business, cybersecurity, and technology industry experience.
Our Advisory Board’s mission is to level the playing field for women who want to lead in the cybersecurity industry.

Johnson & Johnson Expands Commitment to Advance Health Equity

Retrieved on:

Wednesday, April 3, 2024

Johnson & Johnson announced today that it is collaborating with more than 100 community-led health organizations supporting historically marginalized communities across the United States — building on the Company’s multiyear, multimillion-dollar efforts to improve health equity.

Key Points:

Johnson & Johnson announced today that it is collaborating with more than 100 community-led health organizations supporting historically marginalized communities across the United States — building on the Company’s multiyear, multimillion-dollar efforts to improve health equity.
Supporting the work of grassroots organizations, community health centers and national associations is integral to identifying and implementing enduring healthcare solutions,” said Vanessa Broadhurst, Executive Vice President, Global Corporate Affairs at Johnson & Johnson.
Black Women’s Health Imperative aims to empower Black women to take charge of their health through diabetes prevention and self-management classes.
J&J recently held a Health Equity Innovation Challenge to support innovative solutions developed by entrepreneurs and start-ups.

FOX Nation to Release All New “COPS: Spring Break” Collection Beginning This Friday

Retrieved on:

Wednesday, April 3, 2024

FOX Nation will debut a new and exclusive collection of “COPS: Spring Break” episodes beginning on Friday, April 5th.

Key Points:

FOX Nation will debut a new and exclusive collection of “COPS: Spring Break” episodes beginning on Friday, April 5th.
Notably, FOX Nation continues to offer all first responders, including police officers, firefighters, emergency medical technicians and paramedics (EMS personnel), a one-year free subscription to the service.
In this Spring Break special edition, a Pinellas County Deputy learns to play a new game from a group of sun-kissed coeds.
FOX Nation is a direct-to-consumer on-demand streaming service designed to complement the FOX News Channel experience with a members-only destination for its most passionate and loyal super fans.

Research: Surgeons, Hospitals Involved in Exceptional Research Have Lower Patient Mortality Rates, Fewer Complications

Retrieved on:

Wednesday, April 3, 2024

Surgeons and hospitals who conduct the most leading-edge research achieve lower rates of patient mortality and complications than those who do not, according to findings released today by Avant-garde Health.

Key Points:

Surgeons and hospitals who conduct the most leading-edge research achieve lower rates of patient mortality and complications than those who do not, according to findings released today by Avant-garde Health.
Patients under the care of top surgeon-researchers showed a 5% lower rate of post-discharge complications and a 5% lower rate of mortality, within 30 days post-discharge, according to the research.
All 4,500 physicians and 350 hospitals being honored are listed on the Research All-Stars site .
In addition, a significant portion of the top surgeon-researchers – 47.1% on average – served as the leading or senior authors of their research.

Merck Continues the Fight against Schistosomiasis in a Storytelling Lab

Retrieved on:

Tuesday, April 2, 2024

Merck, a leading science and technology company, announced the winners of its 2024 Bilharzia Storytelling Lab in Ethiopia.

Key Points:

Merck, a leading science and technology company, announced the winners of its 2024 Bilharzia Storytelling Lab in Ethiopia.
This innovative initiative aims to develop creative solutions in order to raise awareness about schistosomiasis and, in doing so, bring about behavioral change.
View the full release here: https://www.businesswire.com/news/home/20240402803315/en/
The winners of this year's Merck Bilharzia Storytelling Lab in Ethiopia (Photo: Business Wire)
Schistosomiasis is one of the most prevalent parasitic diseases and affects more than 240 million people worldwide.
Read more about how Merck is committed to eliminating schistosomiasis: www.merckgroup.com/schistosomiasis
View source version on businesswire.com: https://www.businesswire.com/news/home/20240402803315/en/

The Pay Gap is Closing Among Junior VC Investors, New Data Shows

Retrieved on:

Wednesday, March 27, 2024

Consulting, Banking, Accounting, Technology, Professional Services, Small Business, DEI (Diversity, Equity and Inclusion), Apps, Applications, Software, Internet, Finance, Intelligence, Male, Woman, Female, Parity, Traction, Life insurance

Thelander defines total cash as a combination of base pay plus salary, or just base salary, depending on the firm’s compensation structure.

Key Points:

Thelander defines total cash as a combination of base pay plus salary, or just base salary, depending on the firm’s compensation structure.
Median total cash for top investors is $447,500 for women and $500,000 for men, a pay gap of 11%.
“We’re seeing the gender pay gap narrow among more junior roles, which should continue as they progress into more senior positions.
Upon completion of the survey, compensation data is instantly vetted and aggregated, resulting in real-time daily updates on the platform.

Consilio Releases 2023 DEI Report, Highlighting Continued Progress on Gender Representation

Retrieved on:

Tuesday, March 26, 2024

While many organizations are pulling back on their DEI programs, in the report Consilio reaffirms its commitment to these initiatives and outlines those planned for the coming year.

Key Points:

While many organizations are pulling back on their DEI programs, in the report Consilio reaffirms its commitment to these initiatives and outlines those planned for the coming year.
“We’ve made significant strides in our commitment to fostering an inclusive culture at Consilio in the last few years,” said Andy Macdonald, Chief Executive Officer of Consilio.
Expanding DEI Leadership Team – Consilio established its first Senior Leadership position completely dedicated to DEI by appointing James Edwell as Vice President, DEI Partnerships and Communities.
In 2022, the company created the Consilio Leadership Academy (CLA), a 12-month program meant to prepare high-potential leaders for future executive positions at Consilio.